TECTONIC THERAPEUTIC, INC. Deferred State and Local Income Tax Expense (Benefit)
TECTONIC THERAPEUTIC, INC. (TECX) reported Deferred State and Local Income Tax Expense (Benefit) of $4.13 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-26
- TECTONIC THERAPEUTIC, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was $4.13M, a 29.74% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was $3.18M, a 5.36% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was $3.36M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $4.13M 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.18M 10-K · filed 2026-02-26 |
| 2023-12-31 | $3.36M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |